<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to pregabalin (Lyrica) for chronic pain - how it works, conditions treated, dosing, side effects, and important information.">
    <meta name="keywords" content="pregabalin, Lyrica, nerve pain medication, fibromyalgia medication, gabapentinoid">
    <title>Pregabalin (Lyrica) | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Pregabalin (Lyrica)</h1><p>A medication for nerve pain and fibromyalgia</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Pregabalin?</h2>
                <p>Pregabalin (brand name Lyrica) is an anticonvulsant medication that's FDA-approved for several chronic pain conditions. It's related to gabapentin but has more predictable absorption and may work faster. It's commonly used for neuropathic pain, fibromyalgia, and certain seizure disorders.<sup>1</sup></p>

                <h2>FDA-Approved Indications</h2>
                <ul>
                    <li>Diabetic peripheral neuropathy</li>
                    <li>Postherpetic neuralgia (shingles pain)</li>
                    <li>Fibromyalgia</li>
                    <li>Spinal cord injury pain</li>
                    <li>Partial seizures (adjunct)</li>
                    <li>Generalized anxiety disorder (Europe)</li>
                </ul>

                <h2>How It Works<sup>2</sup></h2>
                <ul>
                    <li>Binds to calcium channels in nerves</li>
                    <li>Reduces release of excitatory neurotransmitters</li>
                    <li>Calms overactive nerve signaling</li>
                    <li>More linear absorption than gabapentin</li>
                </ul>

                <h2>Dosing<sup>3</sup></h2>
                <ul>
                    <li>Usually start at 75 mg twice daily</li>
                    <li>May increase to 150 mg twice daily</li>
                    <li>Maximum: 300 mg twice daily (600 mg/day)</li>
                    <li>Adjust for kidney function</li>
                    <li>Takes 1-2 weeks for effect</li>
                </ul>

                <h2>Common Side Effects</h2>
                <ul>
                    <li>Dizziness</li>
                    <li>Drowsiness</li>
                    <li>Weight gain</li>
                    <li>Dry mouth</li>
                    <li>Peripheral edema (swelling)</li>
                    <li>Blurred vision</li>
                    <li>Difficulty concentrating</li>
                </ul>

                <h2>Serious Side Effects</h2>
                <ul>
                    <li>Suicidal thoughts (rare)</li>
                    <li>Severe allergic reactions</li>
                    <li>Angioedema</li>
                    <li>Respiratory depression (with opioids)</li>
                </ul>

                <h2>Important Information</h2>
                <ul>
                    <li>Controlled substance (Schedule V)</li>
                    <li>Potential for misuse/dependence</li>
                    <li>Don't stop suddenlyâ€”taper gradually</li>
                    <li>Avoid alcohol</li>
                    <li>May impair driving</li>
                </ul>

                <h2>Pregabalin vs. Gabapentin</h2>
                <ul>
                    <li>Pregabalin: more predictable absorption</li>
                    <li>Pregabalin: may work faster</li>
                    <li>Pregabalin: twice daily dosing</li>
                    <li>Gabapentin: less expensive</li>
                    <li>Effectiveness similar for many</li>
                </ul>

                <h2>Drug Interactions</h2>
                <ul>
                    <li>Opioids (increased sedation, respiratory risk)</li>
                    <li>Alcohol</li>
                    <li>Benzodiazepines</li>
                    <li>Other CNS depressants</li>
                </ul>

                <h2>Effectiveness</h2>
                <ul>
                    <li>Helps about 30-50% of patients significantly</li>
                    <li>Modest average pain reduction</li>
                    <li>Response varies by individual</li>
                    <li>Give adequate trial before discontinuing</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. <em>Cochrane Database Syst Rev</em>. 2019;1:CD007076.</li>
                    <li>Bockbrader HN, Wesche D, Miller R, et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. <em>Clin Pharmacokinet</em>. 2010;49(10):661-669.</li>
                    <li>Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. <em>Ther Adv Drug Saf</em>. 2014;5(1):38-56.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
